Similar articles

• The HLA-B27 peptidome: building on the cornerstone.

  López de Castro JA. López de Castro JA. Arthritis Rheum. 2010 Feb;62(2):316-9. doi: 10.1002/art.27188. Arthritis Rheum. 2010. PMID: 20112362 No abstract available.
• From retrospective analysis of patients with undifferentiated spondyloarthritis (SpA) to analysis of prospective cohorts and detection of axial and peripheral SpA.

  Burgos-Vargas R, Casasola-Vargas JC. Burgos-Vargas R, et al. J Rheumatol. 2010 Jun;37(6):1091-5. doi: 10.3899/jrheum.100413. J Rheumatol. 2010. PMID: 20516036 No abstract available.
• HLA-B27 transgenic rat: an animal model mimicking gut and joint involvement in human spondyloarthritides.

  Milia AF, Ibba-Manneschi L, Manetti M, Benelli G, Messerini L, Matucci-Cerinic M. Milia AF, et al. Ann N Y Acad Sci. 2009 Sep;1173:570-4. doi: 10.1111/j.1749-6632.2009.04757.x. Ann N Y Acad Sci. 2009. PMID: 19758201 Review.
• Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability.

  Dhaenens M, Fert I, Glatigny S, Haerinck S, Poulain C, Donnadieu E, Hacquard-Bouder C, André C, Elewaut D, Deforce D, Breban M. Dhaenens M, et al. Arthritis Rheum. 2009 Sep;60(9):2622-32. doi: 10.1002/art.24780. Arthritis Rheum. 2009. PMID: 19714626
• Mechanisms of disease: infection and spondyloarthritis.

  Inman RD. Inman RD. Nat Clin Pract Rheumatol. 2006 Mar;2(3):163-9. doi: 10.1038/ncprheum0118. Nat Clin Pract Rheumatol. 2006. PMID: 16932676 Review.